MedPath

Patients With Acute Renal Failure During Severe COVID-19

Conditions
Renal Failure Chronic
Registration Number
NCT05077163
Lead Sponsor
University Hospital, Strasbourg, France
Brief Summary

The occurrence of renal failure during severe forms of COVID-19 is common (20-35% of patients treated in intensive care) and associated with an unfavorable short-term prognosis, but the medium-term renal outcome is not is not known.

The aim of the study is to establish the frequency of chronic kidney failure after AKI KDIGO 2 and 3 occurring during severe COVID-19 in intensive care.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Retrospective study of renal development in patients with acute renal failure during severe COVID-19Files analysed retrospectively from February 01, 2020 to July 31, 2020 will be examined]
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Service de Néphrologie et Transplantation - Hôpitaux Universitaires de Strasbourg

🇫🇷

Strasbourg, France

Service de Néphrologie et Transplantation - Hôpitaux Universitaires de Strasbourg
🇫🇷Strasbourg, France
Bruno MOULIN, MD, PhD
Principal Investigator
Saïd CHAYER, PhD, HDR
Contact
said.chayer@chru-strasbourg.fr
Jonas MARTZLOFF, MD
Sub Investigator
Raphaël KORMANN, MD
Sub Investigator
Vincent DUPONT, MD
Sub Investigator
Clément BALDACINI, MD
Sub Investigator
Sophie CAILLARD, MD, PhD
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.